The Department of Chemistry has submitted a Statement of Intent for a proposed Master in Pharmaceutical Biotechnology (MPB) for approval under the Institutional Quality Assurance Processes (IQAP).

As part of the process, the Statement is being made available for the information of the University community to allow the opportunity for comment prior to moving to the next step in the IQAP.

The Statement of Intent can be viewed on the Office of the Provost and Vice-President, Academic website. The posting will remain in place for 21 days — until 4:30 p.m. on Thursday, Sept. 26.

Comments on the above Statement must be submitted by Thursday, Sept. 26 by email to the Academic Review Committee via the Vice-Chair Brian Power and Chemistry Department Chair Paul Zelisko. In submitting a response, please include the new program title in the subject line.